Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Galapagos N.V.
DescriptionIntegrin receptor antagonist
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetic retinopathy
Indication DetailsTreat diabetic retinopathy with or without diabetic macular edema (DME)
Regulatory Designation
PartnerThromboGenics N.V.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today